Jana Care

Jana Care develops a smartphone-enabled health testing system that enables patients to monitor chronic conditions from home using a drop of blood, a paper test strip, and a mobile app. The company proprietary device, Aina, turns any smartphone into a diagnostic platform capable of measuring blood glucose, lipids, creatinine, and hemoglobin, providing lab-quality results without requiring in-person lab visits. The system operates through a three-step process: patients perform prescribed tests at home with step-by-step guidance from the mobile app, test data is captured by Aina and securely uploaded for clinical review, and healthcare providers receive results immediately to guide ongoing care. Jana Care addresses the critical problem of treatment delays caused by waiting for lab results, which can have serious consequences for conditions like heart failure and kidney disease. The platform enables early detection and real-time monitoring, allowing care teams to act quickly when issues arise. The system is telehealth compatible, providing doctors with lab-quality results from home, improving patient compliance, and giving clinicians continuous access to clinically relevant health data. Jana Care serves patients managing chronic conditions, caregivers who need tools to monitor loved ones health remotely, and clinicians who require ongoing patient data. The company Habits program, based on the diabetes prevention program curriculum, includes a mobile app for tracking calorie and fat intake, meal suggestions, and goal setting for weight loss and physical activity. Founded in 2011 and headquartered in Newton, Massachusetts, Jana Care has raised approximately $35.7 million in Series C funding from investors including Agent Capital, IAG Capital Partners, First Avenue Ventures, Patamar Capital, HealthXCapital, TEAMFund, Department of Biotechnology, and Grand Challenges.